Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study

Cutland, Clare; Nolan, Terry; Halperin, Scott; Kurugol, Z.; Ahmed, Khatija; Perrett, Kirsten; Richmond, Peter; Marshall, Helen; CEYHAN, MEHMET; Kolhe, Devayani; Hezareh, Marjan; Van Der Wielen, Marie

doi:10.1016/j.vaccine.2018.02.013

Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study

Atıf İçin Kopyala

Cutland C. L. , Nolan T., Halperin S. A. , Kurugol Z. A. , Ahmed K., Perrett K. P. , ...Daha Fazla

VACCINE, cilt.36, ss.1908-1916, 2018 (SCI İndekslerine Giren Dergi)

Cilt numarası: 36 Konu: 14
Basım Tarihi: 2018
Doi Numarası: 10.1016/j.vaccine.2018.02.013
Dergi Adı: VACCINE
Sayfa Sayıları: ss.1908-1916

Özet

Background: We evaluated the immunogenicity and safety of 1 and 2 doses of quadrivalent meningococcal serogroup A, C, W and Y tetanus toxoid-conjugate vaccine (MenACWY-IT) given alone or co administered with 13-valent pneumococcal conjugate vaccine (PCV13) in toddlers.